Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E0L |
Pleural Cavity
|
3E0L0 |
Open
|
3E0L05 |
Adhesion Barrier
|
3E0L05Z
|
No Qualifier
Introduction of Adhesion Barrier into Pleural Cavity, Open Approach
|
3E0L3 |
Percutaneous
|
3E0L30 |
Antineoplastic
|
3E0L304
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach
|
3E0L305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach
|
3E0L30M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach
|
3E0L32 |
Anti-infective
|
3E0L328
|
Oxazolidinones
Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach
|
3E0L329
|
Other Anti-infective
Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach
|
3E0L33 |
Anti-inflammatory
|
3E0L33Z
|
No Qualifier
Introduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach
|
3E0L35 |
Adhesion Barrier
|
3E0L35Z
|
No Qualifier
Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach
|
3E0L36 |
Nutritional Substance
|
3E0L36Z
|
No Qualifier
Introduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach
|
3E0L37 |
Electrolytic and Water Balance Substance
|
3E0L37Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach
|
3E0L3B |
Anesthetic Agent
|
3E0L3BZ
|
No Qualifier
Introduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach
|
3E0L3G |
Other Therapeutic Substance
|
3E0L3GC
|
Other Substance
Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach
|
3E0L3H |
Radioactive Substance
|
3E0L3HZ
|
No Qualifier
Introduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach
|
3E0L3K |
Other Diagnostic Substance
|
3E0L3KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach
|
3E0L3N |
Analgesics, Hypnotics, Sedatives
|
3E0L3NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach
|
3E0L3S |
Gas
|
3E0L3SF
|
Other Gas
Introduction of Other Gas into Pleural Cavity, Percutaneous Approach
|
3E0L3T |
Destructive Agent
|
3E0L3TZ
|
No Qualifier
Introduction of Destructive Agent into Pleural Cavity, Percutaneous Approach
|
3E0L4 |
Percutaneous Endoscopic
|
3E0L45 |
Adhesion Barrier
|
3E0L45Z
|
No Qualifier
Introduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach
|
3E0L4G |
Other Therapeutic Substance
|
3E0L4GC
|
Other Substance
Introduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach
|
3E0L7 |
Via Natural or Artificial Opening
|
3E0L70 |
Antineoplastic
|
3E0L704
|
Liquid Brachytherapy Radioisotope
Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening
|
3E0L705
|
Other Antineoplastic
Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening
|
3E0L70M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening
|
3E0L7S |
Gas
|
3E0L7SF
|
Other Gas
Introduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening
|